Search

everythinglearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

The biofilm enhances skin healing by promoting cell growth and blood vessel formation.

Increasing sebum production might help reduce fat and improve metabolism.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

GLP-1RA therapy may increase the risk of hair loss.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Curcumin supplements increase adiponectin and decrease leptin in adults.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Mealworm protein helps fat cell development and may aid in metabolic health and hair growth.

TGFβ signaling prevents sebaceous gland cells from producing fats.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

The new gel effectively treats psoriasis with minimal side effects.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Two sisters with lipoedematous scalp suggest a genetic influence in the condition.

CRH promotes fat production in skin cells, affecting conditions like acne.

Weight-loss drugs are not linked to suicidal thoughts.